文献速递胃肠外科

完全微创与混合Ivor-Lewis食管切除术治疗食管及胃食管交界处癌的英国多中心对比研究

Completely minimally invasive versus hybrid Ivor-Lewis oesophagectomy for oesophageal and gastro-oesophageal junctional cancer: a UK multi-centre comparative study.
PubMed 文献 · Surg Endosc · 2022-01-19

本研究纳入2016至2018年英国三家三级中心接受Ivor-Lewis混合食管切除术(HO)或完全微创食管切除术(CMIO)的382例食管及胃食管交界处癌患者,按ECCG并发症平台评估30天总体并发症。CMIO组30天术后并发症发生率低于HO组(43.5% vs 57.0%,p=0.010),ECCG定义的肺部及感染性并发症在CMIO组更少见,吻合口漏率及肿瘤学结局两组相似。多因素分析显示HO手术方式及高ASA分级是30天术后并发症的独立预测因素。

要点

  • CMIO组30天术后并发症发生率低于HO组(43.5% vs 57.0%,p=0.010)。
  • ECCG定义的肺部及感染性并发症在CMIO组更少见。
  • 两组吻合口漏率及肿瘤学结局相似,HO和高ASA分级是30天并发症独立预测因素。

核心结论

  • Ivor-Lewis CMIO相比Ivor-Lewis HO短期手术结局更优,且不损害肿瘤学可行性。
  • 两组吻合口漏率相当,需随机对照试验验证本研究结果。

研究设计与样本

  • 英国三家三级中心的多中心对比研究,纳入2016至2018年所有连续接受Ivor-Lewis HO或Ivor-Lewis CMIO的食管及胃食管交界处癌患者,共382例。

主要发现

  • 228例(59.7%)接受HO,154例(40.3%)接受CMIO,两组基线无差异。
  • CMIO组30天术后并发症发生率低于HO组(43.5% vs 57.0%,p=0.010)。
  • ECCG定义的肺部及感染性并发症在CMIO组更少见。
  • 两组吻合口漏率及肿瘤学结局相似。
  • 多因素分析显示HO手术方式和高ASA分级是30天术后并发症的独立预测因素。

关键数值与推荐

  • 主要结局为30天总体并发症,按ECCG并发症亚组评估。

临床怎么用

  • 对于可切除食管及胃食管交界处癌,Ivor-Lewis CMIO可考虑作为Ivor-Lewis HO的替代术式,短期并发症更少且肿瘤学可行性相当。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited robust evidence exists comparing outcomes following completely minimally invasive oesophagectomy (CMIO) to hybrid oesophagectomy (HO) in the treatment of resectable oesophageal and gastro-oesophageal junctional (GOJ) cancer. This multi-centre study aims to assess postoperative morbidity between HO and CMIO according to the full Esophagectomy Complications Consensus Group (ECCG) complication platform. METHODS: All consecutive patients undergoing an Ivor-Lewis HO or Ivor-Lewis CMIO for cancer between 2016 and 2018 in three UK tertiary centres were included. The primary study outcome was 30-day overall complications, evaluated by the ECCG complication subgroups. Secondary outcomes included survival outcomes and perioperative parameters between the two approaches. RESULTS: Of the 382 patients included, 228 (59.7%) patients had HOs and 154 (40.3%) patients had CMIOs with no inter-group baseline differences. Patients undergoing CMIO experienced less 30-day postoperative complications compared to those under undergoing HO (43.5% vs 57.0%, p = 0.010). ECCG defined pulmonary and infective complications were less frequent in the CMIO group. Anastomotic leak rates and oncological outcomes were similar between the two groups. Independent predictors of 30-day postoperative complications include surgical approach with HO and high ASA grade on multivariable analysis. CONCLUSIONS: Ivor-Lewis CMIO demonstrates superior short-term surgical outcomes when compared to Ivor-Lewis HO with no compromise in oncological feasibility. Anastomotic leak rates were equivalent between both groups. A robust randomised controlled trial is required to validate the findings of this study.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Patel K, Askari A, Abbassi O, et al. Completely minimally invasive versus hybrid Ivor-Lewis oesophagectomy for oesophageal and gastro-oesophageal junctional cancer: a UK multi-centre comparative study. Surg Endosc. 2022. PMID: 35044515. doi:10.1007/s00464-022-09043-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。